<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cik0001180262="http://www.herbalife.com/20260212"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cik0001180262-20260212.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:RestatementDateAxis">
                    <ecd:RestatementDateAxis.domain>2025-12-31</ecd:RestatementDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:AgwunobiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:AdjustedEBITDAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:AgwunobiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:AdjustedEBITDAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:AgwunobiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:AdjustedEBITDAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:AgwunobiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:AdjustedEBITDAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:AgwunobiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:AdjustedEBITDAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:DrJohnAgwunobiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:DrJohnAgwunobiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:ChangeInFairValueFromPriorYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:ChangeInFairValueFromPriorYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:ChangeInFairValueFromPriorYearEndToTheVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:ChangeInFairValueFromPriorYearEndToTheVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:FairValueAsOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:MrJohnsonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:FairValueAsOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">cik0001180262:GratzianiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:ChangeInFairValueFromPriorYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:ChangeInFairValueFromPriorYearEndToTheVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">cik0001180262:FairValueAsOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001180262</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-89">HERBALIFE LTD.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c1" id="ixv-10697">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:ErrCompAnalysisTextBlock contextRef="c2" id="ixv-5519">

&lt;p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;margin-top:6pt;"&gt;The
Board has adopted a Rule&#160;10&lt;span class="nobreak"&gt;-D-1&lt;/span&gt; clawback policy, compliant with the requirements of the SEC and NYSE
listing standards, that includes a mandatory clawback of excess cash and equity incentive compensation earned by our Section&#160;16 Officers.
Specifically, in the event of a restatement of the Company&#x2019;s financial statements due to material non&lt;span class="nobreak"&gt;-compliance&lt;/span&gt;
with any financial reporting requirement under federal securities laws, the Board or its Compensation Committee shall, among other things,
recoup any excess incentive compensation paid to an executive that was based upon the achievement of financial results that were subsequently
restated. The Company&#x2019;s Amended and Restated 2023 Stock Incentive Plan provides that all awards made thereunder are subject to
the Company&#x2019;s clawback policies.&lt;/p&gt;</ecd:ErrCompAnalysisTextBlock>
    <ecd:PvpTableTextBlock contextRef="c0" id="ixv-9144">

&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;

&lt;table class="Basic-Table" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;"&gt;
  &lt;tr class="Basic-Table _idGenTableRowColumn-14"&gt;
    &lt;td class="Basic-Table H1" style="width: 100.00%; padding: 0in 0in 3px 0in; border-bottom-style:solid; border-bottom-width:1pt;border-bottom-style:solid; border-bottom-color: #23772d;" valign="top"&gt;
        &lt;p class="H1" style="margin:0;padding:0;border-width:0;color:#23772d;font-family:Segoe UI, sans-serif;font-size:12pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:8;margin-left:0;margin-right:0;margin-top:20pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-bottom:8pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Pay
        v. Performance&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:15pt;margin-top:15pt;"&gt;As
discussed under &#x201c;Compensation Discussion and Analysis above&#x201d;, the Committee has implemented an executive compensation program
designed to link a substantial part of each executive&#x2019;s realized compensation to the achievement of the Company&#x2019;s financial
and operating objectives as well as to align executives&#x2019; pay with changes in the value of long&lt;span class="nobreak"&gt;-term&lt;/span&gt;
stakeholder value. As required by Section&#160;953(a)&#160;of the Dodd&lt;span class="nobreak"&gt;-Frank&lt;/span&gt; Wall Street Reform and Consumer
Protection Act, and Item&#160;402(v)&#160;of Regulation&#160;S&lt;span class="nobreak"&gt;-K&lt;/span&gt;, we are providing the following information
regarding the compensation of our named executive officers and the Company&#x2019;s performance.&lt;/p&gt;

&lt;table class="NOGUTTER" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;"&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-26" style="height:12pt;"&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:2pt;padding-right:2pt;width: 5.93%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 9.44%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 9.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 8.15%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" colspan="2" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 14.63%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Value
        of Initial Fixed &lt;br/&gt;$100 Investment Based &lt;br/&gt;on:&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(5)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;padding-bottom:2pt;padding-left:1pt;padding-right:1pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-7"&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:0pt;padding-right:2pt;padding-top:2pt;width: 5.93%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH_left" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:2pt;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 9.44%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Summary
        &lt;br/&gt;Compensation &lt;br/&gt;Table Total &lt;br/&gt;for Agwunobi &lt;br/&gt;($)&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;
        Compensation &lt;br/&gt;Actually Paid &lt;br/&gt;to Agwunobi &lt;br/&gt;($)&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 9.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Summary
        &lt;br/&gt;Compensation &lt;br/&gt;Table Total &lt;br/&gt;for Johnson ($)&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;
        Compensation &lt;br/&gt;Actually Paid &lt;br/&gt;to Johnson &lt;br/&gt;($)&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 8.15%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Summary
        &lt;br/&gt;Compensation &lt;br/&gt;Table Total &lt;br/&gt;for Gratziani&lt;br/&gt;($)&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;
        Compensation &lt;br/&gt;Actually Paid &lt;br/&gt;to Gratziani&lt;br/&gt;($)&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Average
        &lt;br/&gt;Summary &lt;br/&gt;Compensation &lt;br/&gt;Table Total &lt;br/&gt;for Non-C&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;font-variant:normal;text-transform:uppercase;"&gt;eo&lt;/span&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;
        &lt;br/&gt;Named &lt;br/&gt;Executive &lt;br/&gt;Officers &lt;br/&gt;($)&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Average
        &lt;br/&gt;Compensation &lt;br/&gt;Actually Paid &lt;br/&gt;to Non-C&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;font-variant:normal;text-transform:uppercase;"&gt;eo&lt;/span&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;
        &lt;br/&gt;Named &lt;br/&gt;Executive &lt;br/&gt;Officers &lt;br/&gt;($)&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 7.22%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Total
        &lt;br/&gt;Shareholder &lt;br/&gt;Return &lt;br/&gt;($)&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 7.41%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Peer
        Group &lt;br/&gt;Total &lt;br/&gt;Shareholder &lt;br/&gt;Return &lt;br/&gt;($)&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:4pt;"&gt;(6)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:6pt;padding-left:0pt;padding-right:1pt;padding-top:2pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:1pt;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Net
        &lt;br/&gt;Income &lt;br/&gt;($, Mil)&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;padding-bottom:6pt;padding-left:1pt;padding-right:1pt;padding-top:2pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-3" style="font-size:6pt;"&gt;Adjusted
        &lt;br/&gt;&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;font-variant:normal;text-transform:uppercase;"&gt;Ebitda&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-27"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.93%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;2025&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 9.44%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-1"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:5pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 9.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;8,662,643&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:5pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;14,038,978&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.15%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;7,384,841&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;13,146,420&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;1,711,942&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;4,848,432&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.22%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;26.83&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.41%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;71.5&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;228.30&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;634.90&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-27"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.93%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;2024&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 9.44%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:5pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-4"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 9.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;13,207,519&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:5pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;6,835,411&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.15%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-5"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-6"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;4,144,988&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;665,508&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.22%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;13.92&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.41%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;96.25&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;254.30&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;645.8&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-28"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.93%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;2023&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 9.44%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-7"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:5pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-8"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 9.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;1,276,565&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:5pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;1,651,460&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.15%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-9"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-10"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;2,182,473&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;2,481,687&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.22%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;31.76&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.41%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;92.50&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;142.20&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-left-color:#ffffff;border-left-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;600.9&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-29"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.93%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;2022&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 9.44%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;8,178,230&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_bracket" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;(4,173,536)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 9.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;10,342,634&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:5pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;10,733,195&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.15%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-11"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-12"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;2,715,872&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;240,055&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.22%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;30.97&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.41%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;98.14&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;321.30&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-left-color:#ffffff;border-left-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;725.9&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-29"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.93%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;2021&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 9.44%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;6,996,699&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:5pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;3,673,448&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 9.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-13"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:5pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-14"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.15%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-15"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-16"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-17"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-18"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-19"&gt;N/A&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;2,322,262&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 8.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;1,294,288&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.22%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;85.18&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 7.41%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;108.40&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;447.20&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 5.56%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:2pt;"&gt;&lt;span class="CharOverride-6" style="font-size:8pt;"&gt;902.5&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:10pt;margin-top:10pt;"&gt;(1)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;The
Principal Executive Officer and Non&lt;span class="nobreak"&gt;-CEO&lt;/span&gt; Named Executive Officers for the applicable&#160;years were as follows:&lt;/p&gt;


&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2025:
Stephan Gratziani served as CEO starting May 1, 2025, and Mr. Johnson
served as the CEO prior to such date. The Company&#x2019;s other Named Executive Officers for 2025 were: John DeSimone, Henry Wang, Robert
Levy and Frank Lamberti.&lt;/p&gt;

&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2024:
Mr.&lt;span class="nobreak"&gt; &lt;/span&gt;Johnson served as the CEO for the entirety
of 2024. The Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers for 2024 were: John DeSimone, Alexander Amezquita,
Stephan Gratziani, Henry Wang and Frank Lamberti.&lt;/p&gt;

&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2023:
Mr.&#160;Johnson served as the CEO for the entirety of 2023. The Company&#x2019;s
Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers for 2023 were: Alexander Amezquita, Henry Wang, Frank Lamberti and Ibelis
Montesino.&lt;/p&gt;

&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2022:
Mr.&#160;Johnson served as the CEO starting October&#160;27, 2022,
and Dr.&#160;John Agwunobi served as the CEO prior to such date. The Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive
Officers for 2022 were: Alexander Amezquita, Mark Schissel, Henry Wang, Frank Lamberti, John DeSimone and Robert Levy.&lt;/p&gt;


&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2021:
Dr.&#160;John Agwunobi served as the CEO for the entirety of 2021.
The Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers for 2021 were: John DeSimone, Alexander Amezquita,
Alan Hoffman, Mark Schissel and David Pezzullo.&lt;/p&gt;

&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:2pt;"&gt;(2)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Amounts reported in this column represent (i)&#160;the total compensation reported in the Summary Compensation
                    Table for the applicable year in the case of Mr.&#160;Johnson and Mr.&lt;span class="nobreak"&gt; &lt;/span&gt;Gratziani and (ii)&#160;the average
                    of the total compensation reported in the Summary Compensation Table for the applicable year for the Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt;
                    Named Executive Officers.&lt;/p&gt; &lt;/div&gt;

&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;

&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:4pt;margin-top:4pt;"&gt;(3)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Amounts reported in this column represent the compensation actually
                    paid to Mr.&#160;Johnson and Mr.&lt;span class="nobreak"&gt; &lt;/span&gt;Gratziani, based on respective total compensation reported in the Summary
                    Compensation Table for the indicated fiscal&#160;years and adjusted as shown in the table below:&lt;/p&gt;

                    &lt;table class="NOGUTTER" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;"&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-32" style="height:12pt;"&gt;
    &lt;td class="TCH" rowspan="10" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;background-color:#ffffff;padding-left:0pt;width: 3.34%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-right-color:#ffffff;border-right-width:1pt;padding-left:0pt;width: 75.52%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Johnson&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Gratziani&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-32" style="height:12pt;"&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-left:0pt;width: 75.52%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2025&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2025&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-27"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Summary
        Compensation Table&#160;&#x2014;&#160;Total Compensation&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(a)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;$8,662,643&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;$7,384,841&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-27"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;-
        Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(b)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;5,999,990&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;4,199,994&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-33"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(c)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;10,094,380&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;7,278,885&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-33"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Change in Fair Value from Prior Year End of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(d)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2,221,805&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-33"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(e)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-34"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Change in Fair Value from Prior Year End to the Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years For
        Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(f)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;1,281,945&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;460,883&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-33"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;-
        Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years That Failed to Meet Applicable
        Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(g)&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-27"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#000000;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;"&gt;=
        Compensation Actually Paid&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#000000;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;14,038,978&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#000000;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#000000;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;13,146,420&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:5pt;margin-top:2pt;"&gt;(a)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal
                    year.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:5pt;"&gt;(b)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the aggregate grant date fair value of the option awards and stock awards granted to the applicable
                    Named Executive Officer during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;


&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(c)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the aggregate fair value as of the indicated fiscal year&lt;span class="nobreak"&gt;-end&lt;/span&gt;
                    of the applicable Named Executive Officer&#x2019;s outstanding and unvested option awards and stock awards granted during such fiscal
                    year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(d)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the aggregate change in fair value during the indicated fiscal year of the outstanding and
                    unvested option awards and stock awards held by the applicable Named Executive Officer as of the last&#160;day of the indicated fiscal
                    year, computed in accordance with FASB ASC&#160;718 and, for awards subject to performance&lt;span class="nobreak"&gt;-based&lt;/span&gt; vesting
                    conditions, based on the probable outcome of such performance&lt;span class="nobreak"&gt;-based&lt;/span&gt; vesting conditions as of the last&#160;day
                    of the fiscal year.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(e)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the aggregate fair value at vesting of the option awards and stock awards that were granted
                    to the applicable Named Executive Officer and vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;


&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(f)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the aggregate change in fair value, measured from the prior fiscal year&lt;span class="nobreak"&gt;-end&lt;/span&gt;
                    to the vesting date, of each option award and stock award held by the applicable Named Executive Officer that was granted in a prior fiscal
                    year and which vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;


&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(g)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the aggregate fair value as of the last&#160;day of the prior fiscal year of the applicable
                    Named Executive Officer&#x2019;s option awards and stock awards that were granted in a prior fiscal year and which failed to meet the
                    applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;
                    &lt;/div&gt;

&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;

&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:4pt;margin-top:4pt;"&gt;(4)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Amounts reported in this column represent the compensation actually
                    paid to the Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers in the indicated fiscal year, based on the
                    average total compensation for such Named Executive Officers reported in the Summary Compensation Table for the indicated fiscal year
                    and adjusted as shown in the table below:&lt;/p&gt;

                    &lt;table class="NOGUTTER" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;"&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-37" style="height:12pt;"&gt;
    &lt;td class="TCH" rowspan="10" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;background-color:#ffffff;padding-left:0pt;width: 3.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-right-color:#ffffff;border-right-width:1pt;padding-left:0pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;width: 24.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Non-PEO
        Named Executive &lt;br/&gt;Officers&#160;Average&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(a)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-32" style="height:12pt;"&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;padding-left:0pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;width: 24.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:13pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2025&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-38"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Summary
        Compensation Table&#160;&#x2014;&#160;Total Compensation&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(b)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;1,711,942&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-38"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;-
        Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal&#160;Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(c)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;1,478,006&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-39"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(d)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2,553,595&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-39"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Change in Fair Value from Prior Year End of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(e)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;1,740,752&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-39"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(f)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-40"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Change in Fair Value from Prior Year End to the Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years For
        Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(g)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;320,149&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-39"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;-
        Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted&#160;in Prior Fiscal&#160;Years That Failed to Meet Applicable
        Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(h)&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-38"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-9" style="font-size:9pt;font-style:normal;font-weight:bold;"&gt;=
        Compensation Actually Paid&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;4,848,432&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:5pt;margin-top:2pt;"&gt;(a)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Please see footnote 1 above for the Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers included
                    in the average for each indicated fiscal year.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:5pt;"&gt;(b)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the average Total Compensation as reported in the Summary Compensation Table for the reported
                    Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers in the indicated fiscal year.&lt;/p&gt;


&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(c)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the average aggregate grant date fair value of the option awards and stock awards granted
                    to the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers during the indicated fiscal year, computed in accordance
                    with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(d)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the average aggregate fair value as of the indicated fiscal year&lt;span class="nobreak"&gt;-end&lt;/span&gt;
                    of the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers&#x2019; outstanding and unvested option awards and stock
                    awards granted during such fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;


&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(e)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the average aggregate change in fair value during the indicated fiscal year of the outstanding
                    and unvested option awards and stock awards held by the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers as of the
                    last&#160;day of the indicated fiscal year, computed in accordance with FASB ASC&#160;718 and, for awards subject to performance&lt;span class="nobreak"&gt;-based&lt;/span&gt;
                    vesting conditions, based on the probable outcome of such performance&lt;span class="nobreak"&gt;-based&lt;/span&gt; vesting conditions as of the
                    last&#160;day of the fiscal year.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(f)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the average aggregate fair value at vesting of the option awards and stock awards that were
                    granted to the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers and vested during the indicated fiscal year, computed
                    in accordance with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(g)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the average aggregate change in fair value, measured from the prior fiscal year&lt;span class="nobreak"&gt;-end&lt;/span&gt;
                    to the vesting date, of each option award and stock award held by the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers
                    that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;


&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(h)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the average aggregate fair value as of the last&#160;day of the prior fiscal year of the
                    reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers&#x2019; option awards and stock awards that were granted in a prior
                    fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB
                    ASC&#160;718.&lt;/p&gt;

&lt;p class="NL_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:3;margin-left:18pt;margin-top:3pt;text-indent:-18pt;margin-top:3pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;(5)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Pursuant to rules of the SEC, the comparison assumes $100 was invested on December&#160;31, 2020 in
                    our common stock. Historic stock price performance is not necessarily indicative of future stock price performance.&lt;/span&gt;&lt;/p&gt;

&lt;p class="NL_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:3;margin-left:18pt;margin-top:3pt;text-indent:-18pt;margin-top:3pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;(6)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    The TSR Peer Group consists of BellRing Brands, Inc., The Campbell&#x2019;s Company, Church &amp;amp; Dwight
                    Co., Inc., The Clorox Company, Conagra Brands, Inc., Coty Inc., Edgewell Personal Care Company, The Hain Celestial Group, Inc., International
                    Flavors &amp;amp; Fragrances, Inc., The J.M. Smucker Company, Medifast, Inc., McCormick &amp;amp; Company, Incorporated, Nu Skin Enterprises,
                    Inc., Post Holdings, Inc., Spectrum Brands Holdings, Inc., and TreeHouse Foods, Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p class="NL_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:3;margin-left:18pt;margin-top:3pt;text-indent:-18pt;margin-top:3pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;(7)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;For
                    2025, as described in the Compensation Discussion and Analysis, the Committee determined that Adjusted EBITDA, as used under the Company&#x2019;s
                    2025 annual incentive plan, continues to be viewed as a core driver of the Company&#x2019;s performance and shareholder value creation
                    and, accordingly, the Committee selected it as the Company-Selected Measure. Adjusted
                    EBITDA is presented as adjusted for bonus purposes, as discussed in the Compensation Discussion and Analysis relating
                    to our annual incentive plan performance.&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c4" decimals="0" id="ix_9_fact" unitRef="usd">8662643</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c4" decimals="0" id="ix_1_fact" unitRef="usd">14038978</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c5" decimals="0" id="ix_10_fact" unitRef="usd">7384841</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c5" decimals="0" id="ix_2_fact" unitRef="usd">13146420</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c0" decimals="0" id="ix_11_fact" unitRef="usd">1711942</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c0" decimals="0" id="ix_12_fact" unitRef="usd">4848432</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c0" decimals="2" id="ix_40_fact" unitRef="usd">26.83</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c0" decimals="1" id="ix_48_fact" unitRef="usd">71.5</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="2" id="ixv-10706" unitRef="usd">228.3</us-gaap:NetIncomeLoss>
    <ecd:AdjToCompAmt contextRef="c6" decimals="2" id="ixv-10707" unitRef="usd">634.9</ecd:AdjToCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c8" decimals="0" id="ix_3_fact" unitRef="usd">13207519</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c8" decimals="0" id="ix_13_fact" unitRef="usd">6835411</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c1" decimals="0" id="ix_14_fact" unitRef="usd">4144988</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c1" decimals="0" id="ix_35_fact" unitRef="usd">665508</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c1" decimals="2" id="ix_41_fact" unitRef="usd">13.92</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c1" decimals="2" id="ix_42_fact" unitRef="usd">96.25</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c1" decimals="-4" id="ixv-10714" unitRef="usd">254300000</us-gaap:NetIncomeLoss>
    <ecd:AdjToCompAmt contextRef="c10" decimals="1" id="ixv-10715" unitRef="usd">645.8</ecd:AdjToCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c12" decimals="0" id="ix_15_fact" unitRef="usd">1276565</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c12" decimals="0" id="ix_16_fact" unitRef="usd">1651460</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c14" decimals="0" id="ix_17_fact" unitRef="usd">2182473</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c14" decimals="0" id="ix_18_fact" unitRef="usd">2481687</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c14" decimals="2" id="ix_43_fact" unitRef="usd">31.76</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c14" decimals="2" id="ix_44_fact" unitRef="usd">92.5</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c14" decimals="-4" id="ixv-10722" unitRef="usd">142200000</us-gaap:NetIncomeLoss>
    <ecd:AdjToCompAmt contextRef="c15" decimals="1" id="ixv-10723" unitRef="usd">600.9</ecd:AdjToCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c16" decimals="0" id="ix_19_fact" unitRef="usd">8178230</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c16" decimals="0" id="ix_0_fact" unitRef="usd">-4173536</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c17" decimals="0" id="ix_4_fact" unitRef="usd">10342634</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c17" decimals="0" id="ix_5_fact" unitRef="usd">10733195</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c19" decimals="0" id="ix_20_fact" unitRef="usd">2715872</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c19" decimals="0" id="ix_36_fact" unitRef="usd">240055</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c19" decimals="2" id="ix_45_fact" unitRef="usd">30.97</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c19" decimals="2" id="ix_46_fact" unitRef="usd">98.14</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c19" decimals="-4" id="ixv-10732" unitRef="usd">321300000</us-gaap:NetIncomeLoss>
    <ecd:AdjToCompAmt contextRef="c20" decimals="1" id="ixv-10733" unitRef="usd">725.9</ecd:AdjToCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c21" decimals="0" id="ix_21_fact" unitRef="usd">6996699</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c21" decimals="0" id="ix_22_fact" unitRef="usd">3673448</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c24" decimals="0" id="ix_23_fact" unitRef="usd">2322262</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c24" decimals="0" id="ix_24_fact" unitRef="usd">1294288</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c24" decimals="2" id="ix_47_fact" unitRef="usd">85.18</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c24" decimals="2" id="ix_39_fact" unitRef="usd">108.4</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c24" decimals="-4" id="ixv-10740" unitRef="usd">447200000</us-gaap:NetIncomeLoss>
    <ecd:AdjToCompAmt contextRef="c25" decimals="1" id="ixv-10741" unitRef="usd">902.5</ecd:AdjToCompAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c0" id="ixv-9493">

&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:10pt;margin-top:10pt;"&gt;(1)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;The
Principal Executive Officer and Non&lt;span class="nobreak"&gt;-CEO&lt;/span&gt; Named Executive Officers for the applicable&#160;years were as follows:&lt;/p&gt;

&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2025:
Stephan Gratziani served as CEO starting May 1, 2025, and Mr. Johnson
served as the CEO prior to such date. The Company&#x2019;s other Named Executive Officers for 2025 were: John DeSimone, Henry Wang, Robert
Levy and Frank Lamberti.&lt;/p&gt;

&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2024:
Mr.&lt;span class="nobreak"&gt; &lt;/span&gt;Johnson served as the CEO for the entirety
of 2024. The Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers for 2024 were: John DeSimone, Alexander Amezquita,
Stephan Gratziani, Henry Wang and Frank Lamberti.&lt;/p&gt;

&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2023:
Mr.&#160;Johnson served as the CEO for the entirety of 2023. The Company&#x2019;s
Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers for 2023 were: Alexander Amezquita, Henry Wang, Frank Lamberti and Ibelis
Montesino.&lt;/p&gt;

&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2022:
Mr.&#160;Johnson served as the CEO starting October&#160;27, 2022,
and Dr.&#160;John Agwunobi served as the CEO prior to such date. The Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive
Officers for 2022 were: Alexander Amezquita, Mark Schissel, Henry Wang, Frank Lamberti, John DeSimone and Robert Levy.&lt;/p&gt;

&lt;p class="Tablefootnote_m5" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:2pt;"&gt;-&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;2021:
Dr.&#160;John Agwunobi served as the CEO for the entirety of 2021.
The Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers for 2021 were: John DeSimone, Alexander Amezquita,
Alan Hoffman, Mark Schissel and David Pezzullo.&lt;/p&gt;

&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:2pt;"&gt;(2)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Amounts reported in this column represent (i)&#160;the total compensation reported in the Summary Compensation
                    Table for the applicable year in the case of Mr.&#160;Johnson and Mr.&lt;span class="nobreak"&gt; &lt;/span&gt;Gratziani and (ii)&#160;the average
                    of the total compensation reported in the Summary Compensation Table for the applicable year for the Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt;
                    Named Executive Officers.&lt;/p&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c26" id="ixv-10742">Mr. Johnson</ecd:PeoName>
    <ecd:PeoName contextRef="c8" id="ixv-9503">Mr. Johnson</ecd:PeoName>
    <ecd:PeoName contextRef="c12" id="ixv-10743">Mr.&#160;Johnson</ecd:PeoName>
    <ecd:PeoName contextRef="c17" id="ixv-10744">Mr.&#160;Johnson</ecd:PeoName>
    <ecd:PeoName contextRef="c27" id="ixv-10745">Dr.&#160;John Agwunobi</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c0" id="ixv-9537">

&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:4pt;margin-top:4pt;"&gt;(3)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Amounts reported in this column represent the compensation actually
                    paid to Mr.&#160;Johnson and Mr.&lt;span class="nobreak"&gt; &lt;/span&gt;Gratziani, based on respective total compensation reported in the Summary
                    Compensation Table for the indicated fiscal&#160;years and adjusted as shown in the table below:&lt;/p&gt;

                    &lt;table class="NOGUTTER" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;"&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-32" style="height:12pt;"&gt;
    &lt;td class="TCH" rowspan="10" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;background-color:#ffffff;padding-left:0pt;width: 3.34%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-right-color:#ffffff;border-right-width:1pt;padding-left:0pt;width: 75.52%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Johnson&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Gratziani&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-32" style="height:12pt;"&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-left:0pt;width: 75.52%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2025&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2025&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-27"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Summary
        Compensation Table&#160;&#x2014;&#160;Total Compensation&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(a)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;$8,662,643&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;$7,384,841&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-27"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;-
        Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(b)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;5,999,990&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;4,199,994&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-33"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(c)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;10,094,380&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;7,278,885&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-33"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Change in Fair Value from Prior Year End of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(d)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2,221,805&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-33"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(e)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-34"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Change in Fair Value from Prior Year End to the Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years For
        Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(f)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;1,281,945&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;460,883&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-33"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;-
        Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years That Failed to Meet Applicable
        Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(g)&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-27"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#000000;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;"&gt;=
        Compensation Actually Paid&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#000000;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;14,038,978&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#000000;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#000000;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;13,146,420&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:5pt;margin-top:2pt;"&gt;(a)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal
                    year.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:5pt;"&gt;(b)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the aggregate grant date fair value of the option awards and stock awards granted to the applicable
                    Named Executive Officer during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(c)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the aggregate fair value as of the indicated fiscal year&lt;span class="nobreak"&gt;-end&lt;/span&gt;
                    of the applicable Named Executive Officer&#x2019;s outstanding and unvested option awards and stock awards granted during such fiscal
                    year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(d)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the aggregate change in fair value during the indicated fiscal year of the outstanding and
                    unvested option awards and stock awards held by the applicable Named Executive Officer as of the last&#160;day of the indicated fiscal
                    year, computed in accordance with FASB ASC&#160;718 and, for awards subject to performance&lt;span class="nobreak"&gt;-based&lt;/span&gt; vesting
                    conditions, based on the probable outcome of such performance&lt;span class="nobreak"&gt;-based&lt;/span&gt; vesting conditions as of the last&#160;day
                    of the fiscal year.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(e)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the aggregate fair value at vesting of the option awards and stock awards that were granted
                    to the applicable Named Executive Officer and vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(f)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the aggregate change in fair value, measured from the prior fiscal year&lt;span class="nobreak"&gt;-end&lt;/span&gt;
                    to the vesting date, of each option award and stock award held by the applicable Named Executive Officer that was granted in a prior fiscal
                    year and which vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;"&gt;(g)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the aggregate fair value as of the last&#160;day of the prior fiscal year of the applicable
                    Named Executive Officer&#x2019;s option awards and stock awards that were granted in a prior fiscal year and which failed to meet the
                    applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c4" decimals="0" id="ix_6_fact" unitRef="usd">8662643</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c5" decimals="0" id="ix_7_fact" unitRef="usd">7384841</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c28" decimals="0" id="ix_25_fact" unitRef="usd">5999990</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c29" decimals="0" id="ix_26_fact" unitRef="usd">4199994</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c30" decimals="0" id="ix_8_fact" unitRef="usd">10094380</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c31" decimals="0" id="ix_27_fact" unitRef="usd">7278885</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c32" decimals="0" id="ix_49_fact" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c33" decimals="0" id="ix_28_fact" unitRef="usd">2221805</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c34" decimals="0" id="ix_50_fact" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c35" decimals="0" id="ix_51_fact" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c36" decimals="0" id="ix_29_fact" unitRef="usd">1281945</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c37" decimals="0" id="ix_37_fact" unitRef="usd">460883</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c38" decimals="0" id="ix_52_fact" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c39" decimals="0" id="ix_53_fact" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c4" decimals="0" id="ixv-10760" unitRef="usd">14038978</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c5" decimals="0" id="ixv-10761" unitRef="usd">13146420</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c0" id="ixv-9701">

&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:4pt;margin-top:4pt;"&gt;(4)&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Amounts reported in this column represent the compensation actually
                    paid to the Company&#x2019;s Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers in the indicated fiscal year, based on the
                    average total compensation for such Named Executive Officers reported in the Summary Compensation Table for the indicated fiscal year
                    and adjusted as shown in the table below:&lt;/p&gt;

                    &lt;table class="NOGUTTER" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;"&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-37" style="height:12pt;"&gt;
    &lt;td class="TCH" rowspan="10" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;background-color:#ffffff;padding-left:0pt;width: 3.33%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-right-color:#ffffff;border-right-width:1pt;padding-left:0pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;width: 24.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Non-PEO
        Named Executive &lt;br/&gt;Officers&#160;Average&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(a)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-32" style="height:12pt;"&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;padding-left:0pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td class="TCH" style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;width: 24.07%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="TCH" style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:13pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2025&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-38"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;Summary
        Compensation Table&#160;&#x2014;&#160;Total Compensation&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(b)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;1,711,942&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-38"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;-
        Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal&#160;Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(c)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;1,478,006&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-39"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(d)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;2,553,595&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-39"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Change in Fair Value from Prior Year End of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(e)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;1,740,752&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-39"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(f)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-40"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;+
        Change in Fair Value from Prior Year End to the Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years For
        Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(g)&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;320,149&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-39"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;-
        Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted&#160;in Prior Fiscal&#160;Years That Failed to Meet Applicable
        Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(h)&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;0&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr class="NOGUTTER _idGenTableRowColumn-38"&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;" valign="bottom"&gt;
        &lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&lt;span class="CharOverride-9" style="font-size:9pt;font-style:normal;font-weight:bold;"&gt;=
        Compensation Actually Paid&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td class="TB" style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;" valign="top"&gt;
        &lt;p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"&gt;&lt;span class="CharOverride-7" style="font-size:9pt;"&gt;4,848,432&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:5pt;margin-top:2pt;"&gt;(a)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Please see footnote 1 above for the Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers included
                    in the average for each indicated fiscal year.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:5pt;"&gt;(b)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the average Total Compensation as reported in the Summary Compensation Table for the reported
                    Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers in the indicated fiscal year.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(c)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the average aggregate grant date fair value of the option awards and stock awards granted
                    to the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers during the indicated fiscal year, computed in accordance
                    with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(d)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the average aggregate fair value as of the indicated fiscal year&lt;span class="nobreak"&gt;-end&lt;/span&gt;
                    of the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers&#x2019; outstanding and unvested option awards and stock
                    awards granted during such fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(e)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the average aggregate change in fair value during the indicated fiscal year of the outstanding
                    and unvested option awards and stock awards held by the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers as of the
                    last&#160;day of the indicated fiscal year, computed in accordance with FASB ASC&#160;718 and, for awards subject to performance&lt;span class="nobreak"&gt;-based&lt;/span&gt;
                    vesting conditions, based on the probable outcome of such performance&lt;span class="nobreak"&gt;-based&lt;/span&gt; vesting conditions as of the
                    last&#160;day of the fiscal year.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(f)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the average aggregate fair value at vesting of the option awards and stock awards that were
                    granted to the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers and vested during the indicated fiscal year, computed
                    in accordance with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(g)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&#160;&#160;
    Represents the average aggregate change in fair value, measured from the prior fiscal year&lt;span class="nobreak"&gt;-end&lt;/span&gt;
                    to the vesting date, of each option award and stock award held by the reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers
                    that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.&lt;/p&gt;

&lt;p class="Tablefootnote_m4" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;"&gt;(h)&lt;span style="width: 4px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="width: 9px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;
    Represents the average aggregate fair value as of the last&#160;day of the prior fiscal year of the
                    reported Non&lt;span class="nobreak"&gt;-PEO&lt;/span&gt; Named Executive Officers&#x2019; option awards and stock awards that were granted in a prior
                    fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB
                    ASC&#160;718.&lt;/p&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c0" decimals="0" id="ix_30_fact" unitRef="usd">1711942</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c40" decimals="0" id="ix_31_fact" unitRef="usd">1478006</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c41" decimals="0" id="ix_32_fact" unitRef="usd">2553595</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c42" decimals="0" id="ix_33_fact" unitRef="usd">1740752</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c43" decimals="0" id="ix_54_fact" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c44" decimals="0" id="ix_38_fact" unitRef="usd">320149</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c45" decimals="0" id="ix_55_fact" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c0" decimals="0" id="ix_34_fact" unitRef="usd">4848432</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="c0" id="ixv-10775">
    The TSR Peer Group consists of BellRing Brands, Inc., The Campbell&#x2019;s Company, Church &amp;amp; Dwight
                    Co., Inc., The Clorox Company, Conagra Brands, Inc., Coty Inc., Edgewell Personal Care Company, The Hain Celestial Group, Inc., International
                    Flavors &amp;amp; Fragrances, Inc., The J.M. Smucker Company, Medifast, Inc., McCormick &amp;amp; Company, Incorporated, Nu Skin Enterprises,
                    Inc., Post Holdings, Inc., Spectrum Brands Holdings, Inc., and TreeHouse Foods, Inc.</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:NonGaapMeasureDescriptionTextBlock contextRef="c46" id="ixv-10777">For
                    2025, as described in the Compensation Discussion and Analysis, the Committee determined that Adjusted EBITDA, as used under the Company&#x2019;s
                    2025 annual incentive plan, continues to be viewed as a core driver of the Company&#x2019;s performance and shareholder value creation
                    and, accordingly, the Committee selected it as the Company-Selected Measure. Adjusted
                    EBITDA is presented as adjusted for bonus purposes, as discussed in the Compensation Discussion and Analysis relating
                    to our annual incentive plan performance.</ecd:NonGaapMeasureDescriptionTextBlock>
    <ecd:CoSelectedMeasureName contextRef="c0" id="ixv-10778">Adjusted                     EBITDA</ecd:CoSelectedMeasureName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c0" id="ixv-9881">

&lt;p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:12pt;"&gt;&lt;img alt="" src="tlinechart_001.jpg" style="width:520.96px;max-width:100%;"/&gt;&lt;/p&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c0" id="ixv-9897">

&lt;p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:12pt;"&gt;&lt;img alt="" src="tlinechart_002.jpg" style="width:462.08px;max-width:100%;"/&gt;&lt;/p&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c0" id="ixv-9903">

&lt;p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:12pt;"&gt;&lt;img alt="" src="tlinechart_003.jpg" style="width:567.04px;max-width:100%;"/&gt;&lt;/p&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:TabularListTableTextBlock contextRef="c0" id="ixv-9917">

&lt;div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;"&gt;

&lt;p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:10pt;margin-top:10pt;"&gt;The
following is a list of financial performance and other measures, which in the Company&#x2019;s assessment represent the most important
financial and other performance measures used by the Company to link compensation actually paid to the Named Executive Officers for 2025,
as further described under &#x201c;Compensation Discussion and Analysis&#x201d;:&lt;/p&gt;

&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:8pt;margin-right:0;margin-top:4pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-8pt;widows:3;margin-top:6pt;margin-top:6pt;"&gt;&#x2022;&lt;span style="width: 6px;display: inline-block;"&gt;&#160;&#160;&#160;&lt;/span&gt;Adjusted
EBITDA (used in the Company&#x2019;s 2025 Annual Incentive Plan and 2025&lt;span class="nobreak"&gt;-2027&lt;/span&gt;
PSU grants)&lt;/p&gt;

&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:8pt;margin-right:0;margin-top:4pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-8pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"&gt;&#x2022;&#160;Local
Currency Net Sales (used in the Company&#x2019;s 2025 Annual Incentive Plan and 2025&lt;span class="nobreak"&gt;-2027&lt;/span&gt; PSU grants)&lt;/p&gt;
&lt;/div&gt;</ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="c46" id="ixv-9922">EBITDA (used in the Company&#x2019;s 2025 Annual Incentive Plan and 2025-2027 PSU grants)</ecd:MeasureName>
    <ecd:MeasureName contextRef="c47" id="ixv-9925">Local Currency Net Sales (used in the Company&#x2019;s 2025 Annual Incentive Plan and 2025-2027 PSU grants)</ecd:MeasureName>
    <dei:DocumentType contextRef="c0" id="hidden-fact-0">DEF 14A</dei:DocumentType>
    <ecd:PeoTotalCompAmt
      contextRef="c3"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="c3"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="c7"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="c7"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="c9"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="c9"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="c11"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="c11"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="c13"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="c13"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="c18"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="c18"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="c22"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="c22"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="c23"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="c23"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoTotalCompAmt
      contextRef="c23"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="c23"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="c23"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-10801">0001180262</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-10802">false</dei:AmendmentFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-12"
          xlink:label="hidden-fact-12"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-4"
          xlink:label="hidden-fact-4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-19"
          xlink:label="hidden-fact-19"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-8"
          xlink:label="hidden-fact-8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-10"
          xlink:label="hidden-fact-10"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-17"
          xlink:label="hidden-fact-17"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-6"
          xlink:label="hidden-fact-6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-2"
          xlink:label="hidden-fact-2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-14"
          xlink:label="hidden-fact-14"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts reported in this column represent the compensation actually
                    paid to Mr.&#160;Johnson and Mr.<xhtml:span class="nobreak"> </xhtml:span>Gratziani, based on respective total compensation reported in the Summary
                    Compensation Table for the indicated fiscal&#160;years and adjusted as shown in the table below:

                    <xhtml:table
  class="NOGUTTER"
  style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;"><xhtml:tr
      class="NOGUTTER _idGenTableRowColumn-32"
      style="height:12pt;"><xhtml:td
          class="TCH"
          rowspan="10"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;background-color:#ffffff;padding-left:0pt;width: 3.34%; padding: 0in 0in 3px 0in;"
          valign="bottom">
        </xhtml:td><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-right-color:#ffffff;border-right-width:1pt;padding-left:0pt;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="bottom">&#160;</xhtml:td><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="TCH"
              style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">Johnson</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="TCH"
              style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">Gratziani</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr
      class="NOGUTTER _idGenTableRowColumn-32"
      style="height:12pt;"><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;padding-left:0pt;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="bottom">&#160;</xhtml:td><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="TCH"
              style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">2025</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="TCH"
              style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">2025</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-27"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">Summary
        Compensation Table&#160;&#x2014;&#160;Total Compensation</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(a)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">$8,662,643</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">$7,384,841</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-27"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">-
        Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(b)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">5,999,990</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">4,199,994</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-33"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">+
        Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(c)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">10,094,380</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">7,278,885</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-33"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">+
        Change in Fair Value from Prior Year End of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(d)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">0</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">2,221,805</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-33"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">+
        Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(e)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">0</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">0</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-34"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">+
        Change in Fair Value from Prior Year End to the Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years For
        Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(f)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">1,281,945</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">460,883</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-33"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">-
        Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years That Failed to Meet Applicable
        Vesting Conditions During Fiscal Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(g)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">0</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">0</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-27"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#000000;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:top;width: 75.52%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span
                  class="Bold"
                  style="font-style:normal;font-weight:bold;font-size:9pt;">=
        Compensation Actually Paid</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#000000;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">14,038,978&#160;</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#000000;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-right-color:#000000;border-top-color:#ffffff;border-top-width:1pt;padding-bottom:3pt;padding-right:0pt;padding-top:3pt;vertical-align:top;width: 10.57%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">13,146,420</xhtml:span></xhtml:p></xhtml:td></xhtml:tr></xhtml:table><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:5pt;margin-top:2pt;">(a)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span><xhtml:span style="width: 9px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>
    Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal
                    year.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:5pt;">(b)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>&#160;&#160;
    Represents the aggregate grant date fair value of the option awards and stock awards granted to the applicable
                    Named Executive Officer during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;">(c)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span><xhtml:span style="width: 9px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>
    Represents the aggregate fair value as of the indicated fiscal year<xhtml:span class="nobreak">-end</xhtml:span>
                    of the applicable Named Executive Officer&#x2019;s outstanding and unvested option awards and stock awards granted during such fiscal
                    year, computed in accordance with FASB ASC&#160;718.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;">(d)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>&#160;&#160;
    Represents the aggregate change in fair value during the indicated fiscal year of the outstanding and
                    unvested option awards and stock awards held by the applicable Named Executive Officer as of the last&#160;day of the indicated fiscal
                    year, computed in accordance with FASB ASC&#160;718 and, for awards subject to performance<xhtml:span class="nobreak">-based</xhtml:span> vesting
                    conditions, based on the probable outcome of such performance<xhtml:span class="nobreak">-based</xhtml:span> vesting conditions as of the last&#160;day
                    of the fiscal year.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;">(e)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span><xhtml:span style="width: 9px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>
    Represents the aggregate fair value at vesting of the option awards and stock awards that were granted
                    to the applicable Named Executive Officer and vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;">(f)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span><xhtml:span style="width: 9px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>
    Represents the aggregate change in fair value, measured from the prior fiscal year<xhtml:span class="nobreak">-end</xhtml:span>
                    to the vesting date, of each option award and stock award held by the applicable Named Executive Officer that was granted in a prior fiscal
                    year and which vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:4pt;margin-top:4pt;">(g)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>&#160;&#160;
    Represents the aggregate fair value as of the last&#160;day of the prior fiscal year of the applicable
                    Named Executive Officer&#x2019;s option awards and stock awards that were granted in a prior fiscal year and which failed to meet the
                    applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-12"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-4"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-19"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-8"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-10"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-17"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-6"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-2"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-14"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-15"
          xlink:label="hidden-fact-15"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-3"
          xlink:label="hidden-fact-3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-5"
          xlink:label="hidden-fact-5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-18"
          xlink:label="hidden-fact-18"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-9"
          xlink:label="hidden-fact-9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-11"
          xlink:label="hidden-fact-11"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-7"
          xlink:label="hidden-fact-7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-13"
          xlink:label="hidden-fact-13"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-1"
          xlink:label="hidden-fact-1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-16"
          xlink:label="hidden-fact-16"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts reported in this column represent (i)&#160;the total compensation reported in the Summary Compensation
                    Table for the applicable year in the case of Mr.&#160;Johnson and Mr.<xhtml:span class="nobreak"> </xhtml:span>Gratziani and (ii)&#160;the average
                    of the total compensation reported in the Summary Compensation Table for the applicable year for the Company&#x2019;s Non<xhtml:span class="nobreak">-PEO</xhtml:span>
                    Named Executive Officers.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-15"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-3"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-5"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-18"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-9"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-11"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-7"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-13"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-1"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-16"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal
                    year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the aggregate fair value as of the indicated fiscal year<xhtml:span class="nobreak">-end</xhtml:span>
                    of the applicable Named Executive Officer&#x2019;s outstanding and unvested option awards and stock awards granted during such fiscal
                    year, computed in accordance with FASB ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_35_fact"
          xlink:label="ix_35_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_36_fact"
          xlink:label="ix_36_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_9_footnote" xlink:label="ix_9_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts reported in this column represent the compensation actually
                    paid to the Company&#x2019;s Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers in the indicated fiscal year, based on the
                    average total compensation for such Named Executive Officers reported in the Summary Compensation Table for the indicated fiscal year
                    and adjusted as shown in the table below:

                    <xhtml:table
  class="NOGUTTER"
  style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 3pt 0;"><xhtml:tr
      class="NOGUTTER _idGenTableRowColumn-37"
      style="height:12pt;"><xhtml:td
          class="TCH"
          rowspan="10"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;background-color:#ffffff;padding-left:0pt;width: 3.33%; padding: 0in 0in 3px 0in;"
          valign="bottom">
        </xhtml:td><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-right-color:#ffffff;border-right-width:1pt;padding-left:0pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom">&#160;</xhtml:td><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="TCH"
              style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">Non-PEO
        Named Executive <xhtml:br/>Officers&#160;Average</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(a)</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr
      class="NOGUTTER _idGenTableRowColumn-32"
      style="height:12pt;"><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;padding-left:0pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom">&#160;</xhtml:td><xhtml:td
          class="TCH"
          style="background-color:#23772d;border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:6pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="TCH"
              style="margin:0;padding:0;border-width:0;color:#ffffff;font-family:Segoe UI Semibold, sans-serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:600;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:13pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">2025</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-38"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">Summary
        Compensation Table&#160;&#x2014;&#160;Total Compensation</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(b)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">1,711,942</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-38"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">-
        Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal&#160;Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(c)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">1,478,006</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-39"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">+
        Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards Granted in Fiscal Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(d)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">2,553,595</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-39"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">+
        Change in Fair Value from Prior Year End of Outstanding and Unvested Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(e)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">1,740,752</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-39"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">+
        Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(f)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">0</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-40"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">+
        Change in Fair Value from Prior Year End to the Vesting Date of Option Awards and Stock Awards Granted in Prior Fiscal&#160;Years For
        Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(g)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">320,149</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-39"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">-
        Fair Value as of Prior Fiscal Year-End of Option Awards and Stock Awards Granted&#160;in Prior Fiscal&#160;Years That Failed to Meet Applicable
        Vesting Conditions During Fiscal Year</xhtml:span><xhtml:span
                  class="Superscript"
                  style="vertical-align:super;font-size:6pt;">(h)</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;border-bottom-color:#ffffff;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">0</xhtml:span></xhtml:p></xhtml:td></xhtml:tr><xhtml:tr class="NOGUTTER _idGenTableRowColumn-38"><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-width:1pt;border-right-color:#ffffff;border-right-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-left:0pt;padding-top:5pt;width: 72.59%; padding: 0in 0in 3px 0in;"
          valign="bottom"><xhtml:p
              class="Tbody-ind_1"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><xhtml:span
                  class="CharOverride-9"
                  style="font-size:9pt;font-style:normal;font-weight:bold;">=
        Compensation Actually Paid</xhtml:span></xhtml:p></xhtml:td><xhtml:td
          class="TB"
          style="border-bottom-style:solid;border-bottom-width:0pt;border-left-style:solid;border-left-width:0pt;border-right-style:solid;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:4pt;vertical-align:bottom;background-color:#e6e7e8;border-bottom-width:1pt;border-left-color:#ffffff;border-left-width:1pt;border-top-color:#ffffff;border-top-width:1pt;padding-top:5pt;vertical-align:top;width: 24.07%; padding: 0in 0in 3px 0in;"
          valign="top"><xhtml:p
              class="Tbody_rightalign"
              style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:6pt;"><xhtml:span class="CharOverride-7" style="font-size:9pt;">4,848,432</xhtml:span></xhtml:p></xhtml:td></xhtml:tr></xhtml:table><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:5pt;margin-top:2pt;">(a)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span><xhtml:span style="width: 9px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>
    Please see footnote 1 above for the Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers included
                    in the average for each indicated fiscal year.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:5pt;">(b)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>&#160;&#160;
    Represents the average Total Compensation as reported in the Summary Compensation Table for the reported
                    Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers in the indicated fiscal year.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;">(c)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span><xhtml:span style="width: 9px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>
    Represents the average aggregate grant date fair value of the option awards and stock awards granted
                    to the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers during the indicated fiscal year, computed in accordance
                    with FASB ASC&#160;718.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;">(d)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>&#160;&#160;
    Represents the average aggregate fair value as of the indicated fiscal year<xhtml:span class="nobreak">-end</xhtml:span>
                    of the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers&#x2019; outstanding and unvested option awards and stock
                    awards granted during such fiscal year, computed in accordance with FASB ASC&#160;718.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;">(e)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span><xhtml:span style="width: 9px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>
    Represents the average aggregate change in fair value during the indicated fiscal year of the outstanding
                    and unvested option awards and stock awards held by the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers as of the
                    last&#160;day of the indicated fiscal year, computed in accordance with FASB ASC&#160;718 and, for awards subject to performance<xhtml:span class="nobreak">-based</xhtml:span>
                    vesting conditions, based on the probable outcome of such performance<xhtml:span class="nobreak">-based</xhtml:span> vesting conditions as of the
                    last&#160;day of the fiscal year.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;">(f)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span><xhtml:span style="width: 9px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>
    Represents the average aggregate fair value at vesting of the option awards and stock awards that were
                    granted to the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers and vested during the indicated fiscal year, computed
                    in accordance with FASB ASC&#160;718.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;">(g)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>&#160;&#160;
    Represents the average aggregate change in fair value, measured from the prior fiscal year<xhtml:span class="nobreak">-end</xhtml:span>
                    to the vesting date, of each option award and stock award held by the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers
                    that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</xhtml:p><xhtml:p
  class="Tablefootnote_m4"
  style="margin:0;padding:0;border-width:0;font-family:Segoe UI, sans-serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:18pt;margin-right:0;margin-top:2pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:36pt;margin-top:3pt;margin-top:3pt;">(h)<xhtml:span style="width: 4px;display: inline-block;">&#160;&#160;&#160;</xhtml:span><xhtml:span style="width: 9px;display: inline-block;">&#160;&#160;&#160;</xhtml:span>
    Represents the average aggregate fair value as of the last&#160;day of the prior fiscal year of the
                    reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers&#x2019; option awards and stock awards that were granted in a prior
                    fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB
                    ASC&#160;718.</xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_35_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_36_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the aggregate grant date fair value of the option awards and stock awards granted to the applicable
                    Named Executive Officer during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_49_fact"
          xlink:label="ix_49_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the aggregate change in fair value during the indicated fiscal year of the outstanding and
                    unvested option awards and stock awards held by the applicable Named Executive Officer as of the last&#160;day of the indicated fiscal
                    year, computed in accordance with FASB ASC&#160;718 and, for awards subject to performance<xhtml:span class="nobreak">-based</xhtml:span> vesting
                    conditions, based on the probable outcome of such performance<xhtml:span class="nobreak">-based</xhtml:span> vesting conditions as of the last&#160;day
                    of the fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_49_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_37_fact"
          xlink:label="ix_37_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the aggregate change in fair value, measured from the prior fiscal year<xhtml:span class="nobreak">-end</xhtml:span>
                    to the vesting date, of each option award and stock award held by the applicable Named Executive Officer that was granted in a prior fiscal
                    year and which vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_37_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_54_fact"
          xlink:label="ix_54_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_55_fact"
          xlink:label="ix_55_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_38_fact"
          xlink:label="ix_38_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_10_footnote" xlink:label="ix_10_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Please see footnote 1 above for the Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers included
                    in the average for each indicated fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_54_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_55_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_11_footnote" xlink:label="ix_11_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the average Total Compensation as reported in the Summary Compensation Table for the reported
                    Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers in the indicated fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_12_footnote" xlink:label="ix_12_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the average aggregate grant date fair value of the option awards and stock awards granted
                    to the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers during the indicated fiscal year, computed in accordance
                    with FASB ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_13_footnote" xlink:label="ix_13_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the average aggregate fair value as of the indicated fiscal year<xhtml:span class="nobreak">-end</xhtml:span>
                    of the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers&#x2019; outstanding and unvested option awards and stock
                    awards granted during such fiscal year, computed in accordance with FASB ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_14_footnote" xlink:label="ix_14_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the average aggregate change in fair value during the indicated fiscal year of the outstanding
                    and unvested option awards and stock awards held by the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers as of the
                    last&#160;day of the indicated fiscal year, computed in accordance with FASB ASC&#160;718 and, for awards subject to performance<xhtml:span class="nobreak">-based</xhtml:span>
                    vesting conditions, based on the probable outcome of such performance<xhtml:span class="nobreak">-based</xhtml:span> vesting conditions as of the
                    last&#160;day of the fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_16_footnote" xlink:label="ix_16_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the average aggregate change in fair value, measured from the prior fiscal year<xhtml:span class="nobreak">-end</xhtml:span>
                    to the vesting date, of each option award and stock award held by the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers
                    that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_16_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_46_fact"
          xlink:label="ix_46_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_44_fact"
          xlink:label="ix_44_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_42_fact"
          xlink:label="ix_42_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_43_fact"
          xlink:label="ix_43_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_39_fact"
          xlink:label="ix_39_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_41_fact"
          xlink:label="ix_41_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_48_fact"
          xlink:label="ix_48_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_47_fact"
          xlink:label="ix_47_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_45_fact"
          xlink:label="ix_45_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_40_fact"
          xlink:label="ix_40_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_18_footnote" xlink:label="ix_18_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Pursuant to rules of the SEC, the comparison assumes $100 was invested on December&#160;31, 2020 in
                    our common stock. Historic stock price performance is not necessarily indicative of future stock price performance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_43_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_41_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_47_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_45_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_40_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_19_footnote" xlink:label="ix_19_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The TSR Peer Group consists of BellRing Brands, Inc., The Campbell&#x2019;s Company, Church &amp; Dwight
                    Co., Inc., The Clorox Company, Conagra Brands, Inc., Coty Inc., Edgewell Personal Care Company, The Hain Celestial Group, Inc., International
                    Flavors &amp; Fragrances, Inc., The J.M. Smucker Company, Medifast, Inc., McCormick &amp; Company, Incorporated, Nu Skin Enterprises,
                    Inc., Post Holdings, Inc., Spectrum Brands Holdings, Inc., and TreeHouse Foods, Inc.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_19_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_19_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_19_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_19_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_19_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_51_fact"
          xlink:label="ix_51_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_50_fact"
          xlink:label="ix_50_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the aggregate fair value at vesting of the option awards and stock awards that were granted
                    to the applicable Named Executive Officer and vested during the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_51_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_50_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_52_fact"
          xlink:label="ix_52_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_53_fact"
          xlink:label="ix_53_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_8_footnote" xlink:label="ix_8_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the aggregate fair value as of the last&#160;day of the prior fiscal year of the applicable
                    Named Executive Officer&#x2019;s option awards and stock awards that were granted in a prior fiscal year and which failed to meet the
                    applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_52_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_53_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_15_footnote" xlink:label="ix_15_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the average aggregate fair value at vesting of the option awards and stock awards that were
                    granted to the reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers and vested during the indicated fiscal year, computed
                    in accordance with FASB ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_54_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_17_footnote" xlink:label="ix_17_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the average aggregate fair value as of the last&#160;day of the prior fiscal year of the
                    reported Non<xhtml:span class="nobreak">-PEO</xhtml:span> Named Executive Officers&#x2019; option awards and stock awards that were granted in a prior
                    fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with FASB
                    ASC&#160;718.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_55_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
